Difference between revisions of "Key molecular pathways in ALS"
From MyWiki
Line 1: | Line 1: | ||
{{tip|For very comprehensive pathway diagrams for LMN ALS see, https://files.acrobat.com/a/preview/646bf152-9ef2-4f51-8d4a-cb8e9fc0a4ac}} | {{tip|For very comprehensive pathway diagrams for LMN ALS see, https://files.acrobat.com/a/preview/646bf152-9ef2-4f51-8d4a-cb8e9fc0a4ac}} | ||
− | { | + | {| class="wikitable" |
! Pathway || Type || Activated by || Inhibited by || Activates || Inhibits | ! Pathway || Type || Activated by || Inhibited by || Activates || Inhibits | ||
|- | |- |
Latest revision as of 09:46, 28 February 2018
For very comprehensive pathway diagrams for LMN ALS see, https://files.acrobat.com/a/preview/646bf152-9ef2-4f51-8d4a-cb8e9fc0a4ac
Pathway | Type | Activated by | Inhibited by | Activates | Inhibits |
---|---|---|---|---|---|
NF-kappaB | Inflammatory | ||||
TNF-alpha | |||||
caspase-3 | |||||
AMPK-α1 | |||||
IL-10 | |||||
SARM1 | |||||
PKC | |||||
VEGF |